VANGUARD GROUP INC 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | Denali Therapeutics Inc. DNLI | VANGUARD GROUP INC | 10,834,483 7.840% | 887,385 (+8.92%) | Filing |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | Denali Therapeutics Inc. DNLI | VANGUARD GROUP INC | 9,947,098 7.320% | 1,785,568 (+21.88%) | Filing |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Denali Therapeutics Inc. DNLI | VANGUARD GROUP INC | 8,161,530 6.680% | 236,473 (+2.98%) | Filing |
| 2021-02-10 10:46 am Purchase | 2020-12-31 | 13G | Denali Therapeutics Inc. DNLI | VANGUARD GROUP INC | 7,925,057 6.610% | 1,717,515 (+27.67%) | Filing |